Medical Oncology logo Humana Press logo

Publisher: Humana Press

Related content
Volume 22, Number 3, September 2005

< previous issue | all issues | next issue >

Tumor parameters, clinical and pathological responses, medical management, and survival through time on 710 operable breast cancers
pp. 233-240(8)
Authors: Abrial, C.; Mouret-Reynier, M.; Amat, S.; Sillet-Bach, I.; Bougnoux, P.; Delva, R.; Cure, H.; Dauplat, J.; Penault-Llorca, F.; Chollet, P.

The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: Serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanoma
pp. 241-246(6)
Authors: Tas, Faruk; Oguz, Hilal; Argon, Andaç; Duranyildiz, Derya; Camlica, Hakan; Yasasever, Vildan; Topuz, Erkan

Therapeutic efficacy by recombinant human granulocyte/monocyte-colony stimulating factor on mucositis occurring in patients with oral and oropharynx tumors treated with curative radiotherapy: A multicenter open randomized phase III study
pp. 247-256(10)
Authors: Masucci, Giuseppe; Broman, Peter; Kelly, Charles; Lindahl, Sten; Malmberg, Lena; Reizenstein, Johan; Ålenius, Martin; Lewensohn, Rolf

Phase I trial of infusional cyclophosphamide, doxorubicin, and etoposide plus granulocyte-macrophage colony stimulating factor (GM-CSF) in non-hodgkin's lymphoma
pp. 257-267(11)
Authors: Sparano, Joseph; Negassa, Abdissa; Lansigan, Erick; Locke, Robin; Silva, Chamath; Wiernik, Peter

Paclitaxel, cisplatin, leucovorin, and continuous infusion fluorouracil followed by concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the head and neck: A hellenic cooperative oncology group phase II study
pp. 269-279(11)
Authors: Fountzilas, George; Tolis, Christos; Kalogera-Fountzila, Anna; Misailidou, Despina; Tsekeris, Periklis; Karina, Maria; Nikolaou, Angelos; Samantas, Epaminondas; Makatsoris, Thomas; Athanassiou, Eleni; Skarlos, Dimosthenis; Bamias, Aristotelis; Zamboglou, Nikolas; Economopoulos, Theofanis; Karanastassi, Sophia; Pavlidis, Nicholas; Daniilidis, John

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer
pp. 281-290(10)
Authors: Han, Ji-Youn; Lee, Dae; Lee, Sung; Park, Chun; Kim, Hae; Kim, Eun-A; Yoon, Sung; Lee, Hong; Lee, Jin

Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): Comparison of indolent and progressive disease
pp. 291-302(12)
Authors: Kiaii, Shahryar; Choudhury, Aniruddha; Mozaffari, Fariba; Kimby, Eva; Österborg, Anders; Mellstedt, Håkan

Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases: A multicenter phase II study by the cancer therapeutic research group
pp. 303-312(10)
Authors: Ho, Wing; Ma, B.; Mok, Tony; Yeo, W.; Lai, Paul; Lim, R.; Koh, Jane; Wong, Y.; King, Ann; Leow, C.; Chan, A.

Isolated skeletal muscle recurrence of the paranasal sinus lymphoma in complete remission
pp. 313-317(5)
Authors: Karagol, Hakan; Derin, Duygu; Basaran, Mert; Bavbek, Sevil

Mantle cell lymphoma presenting with paraproteinemia
pp. 319-323(5)
Authors: Rymkiewicz, Grzegorz; Gos, Monika; Błachnio, Katarzyna; Woroniecka, Renata; Swoboda, Paweł; Pieńkowska-Grela, Barbara; Kulińska, Marika; Borawska, Anna; Janik, Przemysław; Walewski, Jan

Book review
pp. 325-325(1)
Author: Racevskis, Janis

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page